Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
PEMAZYRE 13,5 mg COMPRIMIDOS
Tablet
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- PEMIGATINIB — 13.5 mg
- Pharmaceutical form Home Med Cabinet grouping
- Tablet
- Availability in Spain
- The only pack is marketed
Packs
PEMAZYRE 13,5 mg COMPRIMIDOS, 14 comprimidos
14 pcs
National code
Marketed730789Strength of this pack 13.5 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 1211535005Official data
- Marketing authorisation holder
- INCYTE BIOSCIENCES DISTRIBUTION B.V.Official data
- Authorised
- May 10, 2021Official data
- Authority form code
- 40Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.